Potential Anti-Diabetic Benefits of Momordica charantia Extracts on Experimental Diabetes and its Complications

Vinay Basavanaka,Mohammed Naseeruddin Inamdar,Saad Alobid,Mohammed Sharique Ahmed Quad,Sultan Alshehri,Syed Imam Rabbani,Rafiulla Gilkaramen,Ali Ibrahim Almoteer,Syed Mohammed Basheerudd
DOI: https://doi.org/10.3923/ijp.2024.81.91
2024-01-15
International Journal of Pharmacology
Abstract:Background and Objective: The Momordica charantia L. (Cucurbitaceae) plant is a natural medicine that is commonly used in the treatment of a wide range of ailments, including diabetes. The current study validates two common types of extracts (methanolic and water) of Momordica charantia (MC) for antidiabetic effects and compares their efficacy in preventing experimental diabetic complications. Materials and Methods: The rats with a fasting serum glucose level above 200 mg dL–1 at 96 hrs after streptozotocin (STZ) injection were considered diabetic and included in the study. They were administered with any of the three doses (45, 90 or 180 mg kg–1) of methanolic or aqueous extracts of MC based on their respective experimental groups. After 14 and 28 days, parameters such as body weight, serum glucose, lipid profile, hemoglobin content and antioxidant status were recorded. The observations were statistically examined using a One-way ANOVA and p<0.05 indicated significance. Results: According to the research findings, rats with STZ-induced diabetes had a significant (p<0.05) variance in their body weight (177±5.64), serum glucose levels (216.4±3.96), lipid profiles [cholesterol (107.38±3.70), triglycerides (168.68±14.70)], hemoglobin levels (7.5±0.14) and antioxidant status. These effects were found to become more prominent after 14 days of exposure. By providing either methanolic or water extracts of MC at different doses, the STZ-induced alterations in body weight and hyperglycemia were significantly (p<0.05) reversed. Besides, the extracts attenuated the hyperlipidemic, depleted antioxidant stress and improved hemoglobin levels in diabetic rats up to 28 days. Comparing the two extracts, the methanolic extract has shown greater efficacy than the water extract and the effects matches with that of glibenclamide. Conclusion: The findings of the current investigation verify the anti-diabetic potential of the MC and show its ability to serve as an alternate therapy for managing hyperglycemia-induced complications. Besides, attenuation in oxidative stress, diminished hemoglobin level, weight loss and hyperlipidemia, both extracts might benefit diabetic conditions by minimizing the complications related to hyperglycemia.
pharmacology & pharmacy
What problem does this paper attempt to address?